Vasomedical Announces Agreement to Acquire Two China-Based Companies

Further Implements Global Growth Strategy and Strengthens Manufacturing, Distribution and Technology Base

WESTBURY, N.Y.  (August 23, 2011) – Vasomedical, Inc. (“Vasomedical”) (OTC: VASO.PK), a leader in the manufacture and sale of devices for the non-invasive treatment and management of cardiovascular diseases as well as a leader in the sale of diagnostic imaging products through its wholly-owned subsidiary, Vasomedical Healthcare, today announced that its newly formed subsidiary, Vasomedical Global,  has signed an agreement to purchase Life Enhancement Technology Limited and Biox Instruments Co., Ltd., both of which are based in the People’s Republic of China. The purchase agreement for these accretive acquisitions provides for a cash payment at closing of $1,000,000 and the issuance of up to 7,400,000 restricted shares of the Company’s common stock, as well as warrants, part of which issuance is performance based.

Read the release in its entirety here:

The comments are closed.